The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) is one of the most common genitourinary complications in men over 50 years of age and typically presents with lower urinary tract symptoms (LUTS). Classes of medications include α1-adrenoceptor blockers, 5α-reductase inhibitors, and phosphodiesterase 5 inhibitors....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Androl Urol
Main Authors: Gandhi, Jason, Weissbart, Steven J., Smith, Noel L., Kaplan, Steven A., Dagur, Gautam, Zumbo, Anna, Joshi, Gargi, Khan, Sardar Ali
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2017
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422692/
https://ncbi.nlm.nih.gov/pubmed/28540239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.03.57
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados